222 related articles for article (PubMed ID: 36387143)
1. The path towards consensus genome classification of diffuse large B-cell lymphoma for use in clinical practice.
Mendeville M; Roemer MGM; Los-de Vries GT; Chamuleau MED; de Jong D; Ylstra B
Front Oncol; 2022; 12():970063. PubMed ID: 36387143
[TBL] [Abstract][Full Text] [Related]
2. Molecular profiling in diffuse large B-cell lymphoma: why so many types of subtypes?
Morin RD; Arthur SE; Hodson DJ
Br J Haematol; 2022 Feb; 196(4):814-829. PubMed ID: 34467527
[TBL] [Abstract][Full Text] [Related]
3. Genomic characterisation of diffuse large B-cell lymphoma.
Harrington F; Greenslade M; Talaulikar D; Corboy G
Pathology; 2021 Apr; 53(3):367-376. PubMed ID: 33642095
[TBL] [Abstract][Full Text] [Related]
4. Next-Generation Sequencing Highlights of Diffuse Large B-cell Lymphoma in a Tertiary Care Hospital in North India.
Mamgain G; Naithani M; Patra P; Mamgain M; Morang S; Nayak J; Kumar K; Singh S; Bakliwal A; Rajoreya A; Vaniyath S; Chattopadhyay D; Chetia R; Gupta A; Dhingra G; Sundriyal D; Nath UK
Cureus; 2022 Aug; 14(8):e28241. PubMed ID: 36158348
[TBL] [Abstract][Full Text] [Related]
5. Diffuse large B-cell lymphoma.
Li S; Young KH; Medeiros LJ
Pathology; 2018 Jan; 50(1):74-87. PubMed ID: 29167021
[TBL] [Abstract][Full Text] [Related]
6. Molecular Subgroups of Diffuse Large B Cell Lymphoma: Biology and Implications for Clinical Practice.
Weber T; Schmitz R
Curr Oncol Rep; 2022 Jan; 24(1):13-21. PubMed ID: 35060000
[TBL] [Abstract][Full Text] [Related]
7. Genomic profiling using array comparative genomic hybridization define distinct subtypes of diffuse large B-cell lymphoma: a review of the literature.
Tirado CA; Chen W; García R; Kohlman KA; Rao N
J Hematol Oncol; 2012 Sep; 5():54. PubMed ID: 22967872
[TBL] [Abstract][Full Text] [Related]
8. A refined cell-of-origin classifier with targeted NGS and artificial intelligence shows robust predictive value in DLBCL.
Xu-Monette ZY; Zhang H; Zhu F; Tzankov A; Bhagat G; Visco C; Dybkaer K; Chiu A; Tam W; Zu Y; Hsi ED; You H; Huh J; Ponzoni M; Ferreri AJM; Møller MB; Parsons BM; van Krieken JH; Piris MA; Winter JN; Hagemeister FB; Shahbaba B; De Dios I; Zhang H; Li Y; Xu B; Albitar M; Young KH
Blood Adv; 2020 Jul; 4(14):3391-3404. PubMed ID: 32722783
[TBL] [Abstract][Full Text] [Related]
9. Genomics of diffuse large B cell lymphoma.
Koh Y
Blood Res; 2021 Apr; 56(S1):S75-S79. PubMed ID: 33935039
[TBL] [Abstract][Full Text] [Related]
10. Molecular subtyping of diffuse large B-cell lymphoma: update on biology, diagnosis and emerging platforms for practising pathologists.
Gifford GK; Gill AJ; Stevenson WS
Pathology; 2016 Jan; 48(1):5-16. PubMed ID: 27020203
[TBL] [Abstract][Full Text] [Related]
11. Molecular Complexity of Diffuse Large B-Cell Lymphoma: Can It Be a Roadmap for Precision Medicine?
Coccaro N; Anelli L; Zagaria A; Perrone T; Specchia G; Albano F
Cancers (Basel); 2020 Jan; 12(1):. PubMed ID: 31940809
[TBL] [Abstract][Full Text] [Related]
12. The role of next-generation sequencing in understanding the genomic basis of diffuse large B cell lymphoma and advancing targeted therapies.
Dubois S; Jardin F
Expert Rev Hematol; 2016 Mar; 9(3):255-69. PubMed ID: 26652775
[TBL] [Abstract][Full Text] [Related]
13. Diffuse large B-cell lymphoma patient-derived xenograft models capture the molecular and biological heterogeneity of the disease.
Chapuy B; Cheng H; Watahiki A; Ducar MD; Tan Y; Chen L; Roemer MG; Ouyang J; Christie AL; Zhang L; Gusenleitner D; Abo RP; Farinha P; von Bonin F; Thorner AR; Sun HH; Gascoyne RD; Pinkus GS; van Hummelen P; Wulf GG; Aster JC; Weinstock DM; Monti S; Rodig SJ; Wang Y; Shipp MA
Blood; 2016 May; 127(18):2203-13. PubMed ID: 26773040
[TBL] [Abstract][Full Text] [Related]
14. Genetic Subtyping and Phenotypic Characterization of the Immune Microenvironment and MYC/BCL2 Double Expression Reveal Heterogeneity in Diffuse Large B-cell Lymphoma.
Xu-Monette ZY; Wei L; Fang X; Au Q; Nunns H; Nagy M; Tzankov A; Zhu F; Visco C; Bhagat G; Dybkaer K; Chiu A; Tam W; Zu Y; Hsi ED; Hagemeister FB; Sun X; Han X; Go H; Ponzoni M; Ferreri AJM; Møller MB; Parsons BM; van Krieken JH; Piris MA; Winter JN; Li Y; Xu B; Albitar M; You H; Young KH
Clin Cancer Res; 2022 Mar; 28(5):972-983. PubMed ID: 34980601
[TBL] [Abstract][Full Text] [Related]
15. Molecular Subtyping of Diffuse Large B-Cell Lymphoma Using a Novel Quantitative RT-PCR Assay.
Ta R; Santini C; Gou P; Lee G; Tai YC; O'Brien C; Fontecha M; Grant C; Bacon L; Finn S; Vandenberghe E; Quinn F; Dua R; Flavin R
J Mol Diagn; 2021 Mar; 23(3):323-340. PubMed ID: 33385586
[TBL] [Abstract][Full Text] [Related]
16. Among diffuse large B-cell lymphomas, T-cell-rich/histiocyte-rich BCL and CD30+ anaplastic B-cell subtypes exhibit distinct clinical features.
Maes B; Anastasopoulou A; Kluin-Nelemans JC; Teodorovic I; Achten R; Carbone A; De Wolf-Peeters C;
Ann Oncol; 2001 Jun; 12(6):853-8. PubMed ID: 11484964
[TBL] [Abstract][Full Text] [Related]
17. LYmphoid NeXt-Generation Sequencing (LYNX) Panel: A Comprehensive Capture-Based Sequencing Tool for the Analysis of Prognostic and Predictive Markers in Lymphoid Malignancies.
Navrkalova V; Plevova K; Hynst J; Pal K; Mareckova A; Reigl T; Jelinkova H; Vrzalova Z; Stranska K; Pavlova S; Panovska A; Janikova A; Doubek M; Kotaskova J; Pospisilova S
J Mol Diagn; 2021 Aug; 23(8):959-974. PubMed ID: 34082072
[TBL] [Abstract][Full Text] [Related]
18. Biological and Clinical Relevance of Associated Genomic Alterations in MYD88 L265P and non-L265P-Mutated Diffuse Large B-Cell Lymphoma: Analysis of 361 Cases.
Dubois S; Viailly PJ; Bohers E; Bertrand P; Ruminy P; Marchand V; Maingonnat C; Mareschal S; Picquenot JM; Penther D; Jais JP; Tesson B; Peyrouze P; Figeac M; Desmots F; Fest T; Haioun C; Lamy T; Copie-Bergman C; Fabiani B; Delarue R; Peyrade F; André M; Ketterer N; Leroy K; Salles G; Molina TJ; Tilly H; Jardin F
Clin Cancer Res; 2017 May; 23(9):2232-2244. PubMed ID: 27923841
[No Abstract] [Full Text] [Related]
19. Refining diffuse large B-cell lymphoma subgroups using integrated analysis of molecular profiles.
Dubois S; Tesson B; Mareschal S; Viailly PJ; Bohers E; Ruminy P; Etancelin P; Peyrouze P; Copie-Bergman C; Fabiani B; Petrella T; Jais JP; Haioun C; Salles G; Molina TJ; Leroy K; Tilly H; Jardin F;
EBioMedicine; 2019 Oct; 48():58-69. PubMed ID: 31648986
[TBL] [Abstract][Full Text] [Related]
20. Genomic signatures in B-cell lymphoma: How can these improve precision in diagnosis and inform prognosis?
Iqbal J; Naushad H; Bi C; Yu J; Bouska A; Rohr J; Chao W; Fu K; Chan WC; Vose JM
Blood Rev; 2016 Mar; 30(2):73-88. PubMed ID: 26432520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
